China, Aug. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Retrospective cohort study on cancer risk in patients with chronic obstructive pulmonar... Read More
China, Aug. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effects of Casein Peptide Supplementation on Blood Pressure in Adults with High‑Normal ... Read More
China, Aug. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Optimization of Subglottic Pressurization Parameters and Its Therapeutic Mechanisms for... Read More
China, Aug. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Safety and Efficacy of Modified Nasopharyngeal Airway Catheter During Lower Limb Debrid... Read More
China, Aug. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Association Between Dynamic Changes in Gut Microbiota and the Risk and Clinical Outcome... Read More
China, Aug. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Risk Stratification and Prediction of Post-Renal Transplant Pneumocystis Pneumonia Usin... Read More
China, Aug. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Correlation of Laboratory Parameters with Clinical Symptoms and Prognosis in Patients w... Read More
China, Aug. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Research on the Pension Dilemmas and Strategies for Patients with Severe Mental Disorde... Read More
China, Aug. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Optimization of Emergency Treatment Strategies and Prognosis Evaluation for Bacillus ce... Read More
Tokyo, Aug. 17 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062590) titled 'A study of the effectiveness and side effects of first-line amivantamab plu... Read More